Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 166

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 166
---
 if New VIWO were a U.S. domestic issuer. For example, New VIWO are not subject to the proxy rules in the United States and disclosure with respect to New VIWO’s annual general meetings will be governed by Cayman Islands requirements. In addition, New VIWO’s officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions of Section16 of the Exchange Act and the rules thereunder. Therefore, New VIWO’s shareholders may not know on a timely basis when New VIWO’s officers, directors and principal shareholders purchase or sell New VIWO’s Ordinary Shares.

As a foreign private issuer, New VIWO are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq listing standards. These practices may afford less protection to shareholders than they would enjoy if New VIWO complied fully with corporate governance listing standards.

As a foreign private issuer, New VIWO are permitted to take advantage of certain provisions in the Nasdaq listing standards that allow us to follow Cayman Islands law for certain governance matters. Certain corporate governance practices in the Cayman Islands may differ significantly from corporate governance listing standards as, except for general fiduciary duties and duties of care, Cayman Islands law has no corporate governance regime which prescribes specific corporate governance standards. Currently, New VIWO do not intend to rely on home country practice with respect to New VIWO’s corporate governance after New VIWO complete with this Business combination. However, if New VIWO choose to follow home country practice in the future, New VIWO’s shareholders may be afforded less protection than they otherwise would have under corporate governance listing standards applicable to U.S. domestic issuers.

<div align='center'>91</div>

Risks Related to New VIWO’s ordinary shares and Organizational Structure

The price of New VIWO’s ordinary shares likely will be volatile like the shares of other early-stage companies.

The stock markets in general and the markets for early-stage shares have experienced extreme volatility. The market for the ordinary shares of smaller companies such as ours is characterized by significant price volatility when compared to the shares of larger, more established companies that trade on a national securities exchange and have large public floats, and we expect that our share price will be more volatile than the shares of such larger, more established companies for the indefinite future.

In addition to the factors discussed in this “Risk Factors” section, price declines in our ordinary shares could also result from general market and economic conditions and a variety of other factors,